Headlines about Varex Imaging (NASDAQ:VREX) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varex Imaging earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.7673083298105 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Varex Imaging (NASDAQ VREX) opened at $36.21 on Wednesday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.60 and a current ratio of 3.25. Varex Imaging has a one year low of $27.80 and a one year high of $43.76. The stock has a market cap of $1,350.23 and a P/E ratio of 26.43.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.23 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.17). Varex Imaging had a net margin of 7.24% and a return on equity of 16.90%. The business had revenue of $176.20 million for the quarter, compared to the consensus estimate of $194.00 million. During the same quarter in the prior year, the business posted $0.37 earnings per share. Varex Imaging’s revenue for the quarter was up 11.9% on a year-over-year basis. analysts predict that Varex Imaging will post 1.87 EPS for the current year.

A number of equities analysts have recently commented on VREX shares. Jefferies Group raised their target price on shares of Varex Imaging to $39.00 and gave the stock a “buy” rating in a research report on Friday, November 10th. Zacks Investment Research lowered shares of Varex Imaging from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Finally, JPMorgan Chase & Co. upgraded shares of Varex Imaging from an “underweight” rating to a “neutral” rating in a research note on Wednesday, December 20th.

In other news, insider Sunny Sanyal sold 50,000 shares of the stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $36.50, for a total transaction of $1,825,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2018/02/14/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-varex-imaging-vrex-share-price.html.

Varex Imaging Company Profile

Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.

Insider Buying and Selling by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.